# Life Science Venture Capital Management

> Life Science Venture Capital Management is a VC fund backing Health Care. See 1 investment, round sizes, portfolio and contact details. Updated Aug 2026.

- Type: VC Fund
- Total investments: 1
- Last investment: Sep 2019
- Lead investor: 0%
- Last updated: Aug 2026

Life Science Venture Capital Management is a VC fund focused on Health Care and Therapeutics. Life Science Venture Capital Management

## Contacts

5 contacts available for Life Science Venture Capital Management. Shizune tracks 1 team members at Life Science Venture Capital Management. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-team-emails/life-science-venture-capital-management?utm_source=investor_profile

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Health Care | 1 | 100% |
| Therapeutics | 1 | 100% |
| Biotechnology | 1 | 100% |
| Pharmaceutical | 1 | 100% |

## Team

| Name | Title | Investments | Profile |
| --- | --- | --- | --- |
| Alexis Yongmei Ji | Venture investor | 6 | https://shizune.co/investors/profile/alexis-yongmei-ji |

## Investments

| Company | Description | Round size | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| STipe Therapeutics | STipe Therapeutics focuses on harnessing the innate immune system to battle cancer. The company has developed first-in-class drugs targeting intracellular protein-protein interactions of the STING Pathway; a major driver of innate immunity, and regulator of tumorigenesis and autoimmune disorders. The company has identified and validated compoundsthat sensitizes the STING pathway and by this modulates the tumor microenvironment to support a potent anti-tumoral response. | $21.8M | Series A | Sep 30, 2019 |  |

1 of 1 investments shown.

## Co-investors
- [Arix Bioscience](https://shizune.co/investors/profile/arix-bioscience) — VC Fund, 1 deal together
- [Novo Holdings](https://shizune.co/investors/profile/novo-a-s) — VC Fund, 1 deal together
- [Sunstone LSV General Partner](https://shizune.co/investors/profile/sunstone-lsv-general-partner) — VC Fund, 1 deal together
- [Wellington Partners](https://shizune.co/investors/profile/wellington-partners) — VC Fund, 1 deal together

## Similar investors

### Similar industry
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [SOSV](https://shizune.co/investors/profile/sosv) — VC Fund

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund

### Similar country
- [Vaekstfonden](https://shizune.co/investors/profile/v%C3%A6kstfonden) — VC Fund
- [PSV](https://shizune.co/investors/profile/preseed-innovation) — VC Fund
- [Seed Capital](https://shizune.co/investors/profile/seed-capital) — VC Fund

## Featured in investor lists
- [Health Care VC Funds in Denmark](https://shizune.co/investors/health-care-vc-funds-denmark)

## FAQ

### What does Life Science Venture Capital Management invest in?

Life Science Venture Capital Management invests primarily in Health Care, Therapeutics and Biotechnology startups, most often at Series A stage. Most of the 1 investments tracked by Shizune back companies in Denmark. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### How do I contact Life Science Venture Capital Management?

For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Who are the partners at Life Science Venture Capital Management?

The team at Life Science Venture Capital Management includes Alexis Yongmei Ji (Venture investor). The Team section lists each member with their title, investment count and links.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co